{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:19:44Z","timestamp":1783095584895,"version":"3.54.6"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.survophthal.2026.06.013","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:22:07Z","timestamp":1782850927000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Macular telangiectasia masqueraders"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9692-6443","authenticated-orcid":false,"given":"Sakshi","family":"Shiromani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sashwanthi","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensington","family":"Hatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3488-9680","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2026.06.013_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12886-020-01485-y","article-title":"Case report: internal limiting membrane drape sign masking by foveal detachment in macular telangiectasia type 2","volume":"20","author":"Abdul-Rahman","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.013_bib2","article-title":"Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2","author":"Amram","year":"2024","journal-title":"British Journal of Ophthalmology [Internet]"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.013_bib3","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/IAE.0000000000000110","article-title":"ASSOCIATIONS BETWEEN AUTOFLUORESCENCE ABNORMALITIES AND VISUAL ACUITY IN IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report Number 5","volume":"34","author":"Balaskas","year":"2014","journal-title":"RETINA"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.013_bib4","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/sj.eye.6702985","article-title":"A case of idiopathic perifoveal Telangiectasia preceded by features of cone dystrophy","volume":"21","author":"Barthelmes","year":"2007","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.013_bib5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.survophthal.2016.03.003","article-title":"Acute macular neuroretinopathy: A comprehensive review of the literature","volume":"61","author":"Bhavsar","year":"2016","journal-title":"Survey of Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.013_bib6","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.4103\/IJO.IJO_78_23","article-title":"Relevance of multicolor imaging, its component channels, and fundus autofluorescence in describing macular telangiectasia type-2 (MacTel) lesion characteristics","volume":"72","author":"Chandran","year":"2024","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.013_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","article-title":"Macular telangiectasia type 2","volume":"34","author":"Charbel Issa","year":"2013","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.013_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/IAE.0000000000000863","article-title":"VERY EARLY DISEASE MANIFESTATIONS OF MACULAR TELANGIECTASIA TYPE 2","volume":"36","author":"Charbel Issa","year":"2016","journal-title":"RETINA"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.013_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2018.09.041","article-title":"Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial","volume":"126","author":"Chew","year":"2019","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.013_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ajo.2014.12.013","article-title":"Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel): Results from a phase I safety trial","volume":"159","author":"Chew","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.013_bib11","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400481","article-title":"Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2","volume":"4","author":"Chew","year":"2025","journal-title":"NEJM Evidence"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100261","article-title":"Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10","volume":"3","author":"Chew","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.013_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5301\/ejo.5000008","article-title":"Fundus autofluorescence patterns in type 2A idiopathic juxtafoveolar retinal telangiectasis","volume":"22","author":"Chhablani","year":"2012","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.013_bib14","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1167\/iovs.08-1749","article-title":"The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project","volume":"49","author":"Clemons","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.013_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/09286580903450361","article-title":"Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2","volume":"17","author":"Clemons","year":"2010","journal-title":"Ophthalmic Epidemiol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.013_bib16","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2500127","article-title":"Ciliary Neurotrophic Factor \u2014 A Promising New Therapy for Macular Telangiectasia Type 2","volume":"4","author":"Duncan","year":"2025","journal-title":"NEJM Evidence"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.013_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s42255-021-00361-3","article-title":"Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease","volume":"3","author":"Eade","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.survophthal.2026.06.013_bib18","doi-asserted-by":"crossref","unstructured":"Enghelberg M., Kaifee S. Suspected Neratinib Macular Toxicity Presenting As Macular Telangiectasia Type II. Cureus. 15(1):e33964. doi:10.7759\/cureus.33964","DOI":"10.7759\/cureus.33964"},{"key":"10.1016\/j.survophthal.2026.06.013_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.survophthal.2025.01.007","article-title":"Perifoveal vascular anomalous complex and telangiectatic capillaries: An overview of two entities potentially sharing a common pathophysiology","author":"Forte","year":"2025","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.013_bib20","first-page":"1536","article-title":"Idiopathic juxtafoveolar retinal telangiectasis","volume":"100","author":"Gass","year":"1993","journal-title":"Update of classification and follow-up study. Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.013_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/jamaophthalmol.2023.6454","article-title":"Self-Supervised Learning for Improved Optical Coherence Tomography Detection of Macular Telangiectasia Type 2","volume":"142","author":"Gholami","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.013_bib22","article-title":"Enhanced Macular Telangiectasia Type 2 Detection: Leveraging Self-Supervised Learning and Ensemble Models","volume":"5","author":"Gholami","year":"2025","journal-title":"Ophthalmology Science [Internet]"},{"key":"10.1016\/j.survophthal.2026.06.013_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101400","article-title":"Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality","volume":"109","author":"Hall","year":"2025","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.013_bib24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.013_bib25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ophtha.2020.03.040","article-title":"Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8","volume":"127","author":"Heeren","year":"2020","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.013_bib26","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/bjophthalmol-2020-318470","article-title":"Morphological characteristics preceding exudative neovascularisation secondary to macular telangiectasia type 2","volume":"106","author":"Hess","year":"2022","journal-title":"British Journal of Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.oret.2022.08.004","article-title":"Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging","volume":"7","author":"Hess","year":"2023","journal-title":"Ophthalmology Retina"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.013_bib28","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.oret.2020.12.009","article-title":"Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5","volume":"5","author":"Jaffe","year":"2021","journal-title":"Ophthalmology Retina"},{"key":"10.1016\/j.survophthal.2026.06.013_bib29","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2147\/OPTH.S373538","article-title":"Macular Telangiectasia Type 2: A Comprehensive Review","volume":"16","author":"Kedarisetti","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00347-008-1863-3","article-title":"Clinical findings and diagnostics of cone dystrophy","volume":"106","author":"Kellner","year":"2009","journal-title":"Ophthalmologe"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ajo.2006.03.021","article-title":"Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography","volume":"142","author":"Koizumi","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.013_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archopht.120.5.567","article-title":"Clinical variations in assessment of bull\u2019s-eye maculopathy","volume":"120","author":"Kurz-Levin","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.013_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101326","article-title":"Exploring retinal conditions through blue light reflectance imaging","volume":"105","author":"Leit\u00e3o Guerra","year":"2025","journal-title":"Progress in Retinal and Eye Research"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.013_bib34","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/IAE.0000000000001842","article-title":"CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA","volume":"38 1","author":"Leung","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.06.013_bib35","unstructured":"l.ferguson@neurotechusa.com. Neurotech\u2019s ENCELTOTM (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment in Adults of Idiopathic Macular Telangiectasia Type 2 (MacTel) [Internet]. neurotech. 2025 [cited 2025 Mar 13]. Available from: \u3008https:\/\/www.neurotechpharmaceuticals.com\/neurotechs-enceltotm-revakinagene-taroretcel-lwey-approved-by-the-fda-for-the-treatment-of-macular-telangiectasia-type-2-mactel\/\u3009"},{"key":"10.1016\/j.survophthal.2026.06.013_bib36","article-title":"Radiation-Induced Optical Coherence Tomography Angiography Retinal Alterations in Patients With Nasopharyngeal Carcinoma","volume":"7","author":"Li","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.013_bib37","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archophthalmol.2009.210","article-title":"A new macular dystrophy with anomalous vascular development, pigment spots, cystic spaces, and neovascularization","volume":"127","author":"Mahajan","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.013_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/ojo.ojo_4_22","article-title":"Intraretinal and subretinal fluid in exudative nonproliferative macular telangiectasia type 2","volume":"15","author":"Manayath","year":"2022","journal-title":"Oman J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib39","article-title":"Macular Telangiectasia Type 2: Case Report and Clinical Review","volume":"33","author":"Mangum","year":"2022","journal-title":"CRO Journal [Internet]"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.013_bib40","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/IAE.0000000000001836","article-title":"Concurrent idiopathic macular telangiectasia type 2 and central serous chorioretinopathy","volume":"38","author":"Matet","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.06.013_bib41","unstructured":"MD BJK BA, Antonio Yaghy, M.D., and Lauren A.Dalvin. An Update on Radiation Retinopathy [Internet]. [cited 2026 Mar 15]. Available from: \u3008https:\/\/www.reviewofophthalmology.com\/article\/an-update-on-radiation-retinopathy\u3009"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.013_bib42","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/IAE.0b013e3182695bb3","article-title":"Prevalence and progression of pigment clumping associated with idiopathic macular telangiectasia type 2","volume":"33","author":"Meleth","year":"2013","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.013_bib43","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/bjo.2007.118356","article-title":"ABCA4 mutations and discordant ABCA4 alleles in patients and siblings with bull\u2019s-eye maculopathy","volume":"91","author":"Michaelides","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"14","key":"10.1016\/j.survophthal.2026.06.013_bib44","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.3390\/ijms23147849","article-title":"Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2","volume":"23","author":"Moir","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.013_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4274\/tjo.68335","article-title":"Optic Coherence Angiography Findings in Type-2 Macular Telangiectasia","volume":"47","author":"Nalc\u0131","year":"2017","journal-title":"Turk J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3928\/23258160-20150213-17","article-title":"Spectral-domain optical coherence tomography measurements of choroidal thickness and outer retinal disruption in macular telangiectasia type 2","volume":"46","author":"Nunes","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.013_bib47","doi-asserted-by":"crossref","first-page":"e998","DOI":"10.1111\/aos.14110","article-title":"Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2","volume":"97","author":"Pauleikhoff","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.013_bib48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajo.2021.03.022","article-title":"Fundus Autofluorescence Imaging in Macular Telangiectasia Type 2: MacTel Study Report Number 9","volume":"228","author":"Pauleikhoff","year":"2021","journal-title":"American Journal of Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.013_bib49","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/IAE.0000000000001697","article-title":"CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2","volume":"38","author":"PETO","year":"2018","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.013_bib50","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/IAE.0000000000003851","article-title":"Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Macular Telangiectasia Type 2 (MacTel) Patients with and without Diabetes","volume":"43","author":"Sauer","year":"2023","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.013_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/aos.13174","article-title":"Fundus autofluorescence lifetimes are increased in non-proliferative diabetic retinopathy","volume":"95","author":"Schmidt","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.013_bib52","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1167\/iovs.14-14668","article-title":"Microscopic Inner Retinal Hyper-Reflective Phenotypes in Retinal and Neurologic Disease","volume":"55","author":"Scoles","year":"2014","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.013_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/atm-2026-1-0018","article-title":"Deep learning in geographic atrophy: rethinking age-related macular degeneration progression and treatment","volume":"14","author":"Shiromani","year":"2026","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/ICB.0000000000000550","article-title":"IDENTIFICATION OF INCREASED BLUE LIGHT REFLECTIVITY IN MACULAR TELANGIECTASIA TYPE 2 USING SCANNING LASER OPHTHALMOSCOPY VERSUS RED-FREE FUNDUS PHOTOGRAPHY","volume":"13","author":"Soorma","year":"2019","journal-title":"Retin Cases Brief Rep"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.013_bib55","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1097\/IAE.0000000000002289","article-title":"RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2","volume":"38","author":"Spaide","year":"2018","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.013_bib56","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","article-title":"Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema","volume":"132","author":"Sun","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.013_bib57","first-page":"S33","article-title":"Paracentral acute middle maculopathy and acute macular neuroretinopathy","volume":"44","author":"Tsui","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.013_bib58","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/bjophthalmol-2018-313364","article-title":"Right-angled vessels in macular telangiectasia type 2","volume":"105","author":"Tzaridis","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.013_bib59","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/IAE.0000000000003111","article-title":"HYPERREFLECTIVITY ON OPTICAL COHERENCE TOMOGRAPHY IN MACULAR TELANGIECTASIA TYPE 2","volume":"41","author":"Tzaridis","year":"2021","journal-title":"RETINA"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.013_bib60","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1167\/iovs.19-27055","article-title":"Quantification of Retinal and Choriocapillaris Perfusion in Different Stages of Macular Telangiectasia Type 2","volume":"60","author":"Tzaridis","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.013_bib61","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41433-022-02065-8","article-title":"Characteristics of retinal pigment clumps in Type 2 macular telangiectasia (MacTel)","volume":"37","author":"Venkatesh","year":"2023","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.013_bib62","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41433-023-02853-w","article-title":"Right-angled vessel characteristics in different stages of type 2 macular telangiectasia (MacTel)","volume":"38","author":"Venkatesh","year":"2024","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.013_bib63","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00417-023-06330-8","article-title":"Vitreomacular interface abnormalities in type 2 macular telangiectasia (MacTel)","volume":"262","author":"Venkatesh","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.013_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40942-022-00378-0","article-title":"Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity","volume":"8","author":"Venkatesh","year":"2022","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.survophthal.2026.06.013_bib65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40942-022-00378-0","article-title":"Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity","volume":"8","author":"Venkatesh","year":"2022","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.survophthal.2026.06.013_bib66","article-title":"Tamoxifen retinopathy and macular telangiectasia: A comparative case series","author":"Venkatesh","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.013_bib67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.13.11.2","article-title":"Developing a 10-Layer Retinal Segmentation for MacTel Using Semi-Supervised Learning","volume":"13","author":"Verma","year":"2024","journal-title":"Trans Vis Sci Tech"},{"key":"10.1016\/j.survophthal.2026.06.013_bib68","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/IAE.0000000000001693","article-title":"SCOTOMA CHARACTERISTICS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 7\u2014The MacTel Research Group","volume":"38","author":"Vujosevic","year":"2018","journal-title":"RETINA"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.preteyeres.2011.11.005","article-title":"CNTF and retina","volume":"31","author":"Wen","year":"2012","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.013_bib70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archopht.124.4.450","article-title":"Idiopathic Macular Telangiectasia","volume":"124","author":"Yannuzzi","year":"2006","journal-title":"Archives of Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.013_bib71","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/bjophthalmol-2021-320392","article-title":"Intraretinal pigmented cells in retinal degenerative disease","volume":"107","author":"Yasvoina","year":"2023","journal-title":"British Journal of Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.013_bib72","doi-asserted-by":"crossref","first-page":"816","DOI":"10.4103\/IJO.IJO_962_24","article-title":"OCT angiography findings in type 2 macular telangiectasia: A meta-analysis","volume":"73","author":"Zare Hosseinabadi","year":"2025","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.013_bib73","first-page":"594","article-title":"C. The Role of Diagnostic Imaging in Macular Telangiectasia Type 2","volume":"38","author":"Goman-Baskin","year":"2021","journal-title":"Fed Pract"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.013_bib74","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/diagnostics13020232","article-title":"OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy","volume":"13","author":"Zhang","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.survophthal.2026.06.013_bib76","unstructured":"Macular telangiectasia type 2 - ClinicalKey [Internet]. [cited 2025 Apr 6]. Available from: \u3008https:\/\/www.clinicalkey.com\/#!\/content\/book\/3-s2.0-B9780323722131000664\u3009"},{"key":"10.1016\/j.survophthal.2026.06.013_bib77","unstructured":"ENCELTO for MacTel type 2 | ENCELTOTM (revakinagene taroretcel-lwey) [Internet]. ENCELTOTM (revakinagene taroretcel-lwey) ECP Website. [cited 2026 Mar 15]. Available from: \u3008https:\/\/www.encelto.com\/ecp\/\u3009"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:31:55Z","timestamp":1783092715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726000895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":76,"alternative-id":["S0039625726000895"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.06.013","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macular telangiectasia masqueraders","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}